EU Malaria Fund Enters Post-investment Period
On 30 September, the EU Malaria Fund (EUMF) concluded its investment activities at a high-level online event by finalizing its investments into four innovative companies active in malaria R&D. The EUMF
Stay updated with breaking news from Tobias Mac. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On 30 September, the EU Malaria Fund (EUMF) concluded its investment activities at a high-level online event by finalizing its investments into four innovative companies active in malaria R&D. The EUMF
Press release content from Business Wire. The AP news staff was not involved in its creation. AchilleS Vaccines Completes Industrial Development of Promising Treatment Against SARS-CoV-2 January 25, 2021 GMT AchilleS Vaccines Completes Industrial Development of Promising Treatment Against SARS-CoV-2 (Photo: AchilleS Vaccines) KALKARA, Malta & SIENA, Italy--(BUSINESS WIRE)--Jan 25, 2021-- Today, AchilleS Vaccines, a biotech company based in Siena (Italy), announced the successful industrial development of a novel monoclonal antibody (mAb) to treat COVID-19. The treatment, patented by Prof Rino...
Press release content from Business Wire. The AP news staff was not involved in its creation. kENUP Foundation: EIB and FIND back innovative plant-based reagent manufacturing in Africa to fight COVID-19 and other endemic diseases December 18, 2020 GMT LUXEMBOURG & CAPE TOWN, South Africa & GENEVA--(BUSINESS WIRE)--Dec 18, 2020-- African reagent manufacturing for rapid testing kits and treatment for COVID-19 and other endemic diseases will be transformed by construction of a new Cape Biologix Technologies facility in Mauritius. ADVERTISEMENT Belinda Shaw, CEO Cape Biologix, Mamokgethi Phakeng,...
kENUP Foundation: EIB Launches EUR 50 Million Africa Pharmaceutical Manufacturing Initiative LUXEMBOURG--(Business Wire)--The European Investment Bank today launched the first ever scheme to strengthen local production of Active Pharmaceutical Ingredients in Africa and scale up drug manufacturing essential to improve public health. The EIB’s new EUR 50 million pharmaceutical investment initiative, initiated together with kENUP Foundation, will contribute to reducing dependency on drug imports and address medical supply chain weaknesses linked to COVID-19. kENUP Foundation: EIB Launches EU...
kENUP Foundation: EIB Launches EUR 50 Million Africa Pharmaceutical Manufacturing Initiative The European Investment Bank today launched the first ever scheme to strengthen local production of Active Pharmaceutical Ingredients in Africa and scale up drug manufacturing essential to improve public health. The EIB's new EUR 50 million pharmaceutical investment initiative, initiated together with kENUP Foundation, will contribute to reducing dependency on drug imports and address medical supply chain weaknesses linked to COVID-19. This press release features multimedia. View the full release here...